Business
Currency:USD
2024/Q1
Stock NameRevenueRatio
Finance Receivables11.5M97.63%
Pharmaceutical Development and Other279K2.37%
Region
Currency:USD
2023/FY
Stock NameRevenueRatio
United States37.76M100.00%